SOURCE: HealthSport, Inc.

May 30, 2007 10:05 ET

HealthSport Announces Dr. C.T. Moorman as Sports Advisory Council Chairman

Duke Physician to Lead Council of Athletes, Trainers, and Medical Professionals

AMHERST, NY--(Marketwire - May 30, 2007) - HealthSport, Inc. (OTCBB: HSPO), announced the appointment of Duke University's C.T. Moorman, M.D. as the Chairman of the newly formed Enlyten™ Sports Advisory Council. HealthSport, a publicly traded company under the ticker symbol HSPO, is a fully integrated developer, manufacturer and marketer of branded nutritional supplements in a one-of-a-kind edible film strip delivery system. Dr. Moorman is the Director of the Duke Sports Medicine Center, Head Team Physician for Duke University Athletics, and Associate Professor of Orthopaedic Surgery.

"I am honored to chair the Enlyten Sports Advisory Council as I believe Enlyten's delivery technology will be a great help to athletes at all levels. We have been able to assemble an exceptional team of talented and knowledgeable experts committed to promoting performance and safety. I am excited to be a part of this team," said Dr. Moorman who has previously served as the Director of Sports Medicine at the University of Maryland Medical Center and was the Head Team Physician for the NFL's Baltimore Ravens.

The Sports Advisory Council was formed by HealthSport to help in the research and development of electrolyte strips currently being produced by the Company. The Council will advise and inform HealthSport of all matters pertaining to the importance of hydration and electrolyte replenishment to the athlete during and after training and competition. The individuals named to the Sports Advisory Council provides a unique point of view and will offer opportunities to create awareness of proper hydration to ensure that all athletes maximize their workouts and performance.

HealthSport's marquee product, Enlyten SportStrips™, is a new and unique edible film strip delivery system that replaces the electrolytes lost during vigorous workouts through a patented delivery system. This mode of absorption is very different from all electrolyte delivery predecessors. When placed between the cheek and gum, gastric absorption is bypassed speeding higher levels of electrolytes directly into the bloodstream. Not only does it dramatically improve hydration on a cellular level, but it also helps athletes to avoid the problems caused by excessive fluid consumption which is often associated with sports drinks.

"We have drafted an elite team of experts and athletes to help our Company better understand what an athlete goes through that may result in dehydration and the negative consequences resulting from dehydration. The Sports Advisory Council is comprised of professionals who are committed to a healthy lifestyle and want to educate others about the importance of electrolyte replenishment," said Dan Kelly, President of HealthSport. "We have an opportunity to educate athletes and help improve their training and their health. We truly believe in the members of this Council and we know they will bring the best ideas and most important issues to the table."

Sports Advisory members include Hall of Fame Quarterback Jim Kelly, Miami Dolphins' Defensive End and NFL Defensive Player of the Year Jason Taylor, US Soccer star Brandi Chastain, Buffalo Bills Quarterback JP Losman, Marathon Runner Peter Gilmore, and Duke Medical Research Associate Anthony Seaber. The Company intends to continue to add athletes, trainers, coaches, and researchers to the Sports Advisory Council over the next few months.


If you would like to receive e-mail announcements about HSPO, please sign up at the following website: http://www.Directstocknews.com/HSPO.

About HealthSport, Inc.

HealthSport (http://www.healthsportinc.com) is a fully integrated developer, manufacturer and marketer of unique and proprietary branded and private label edible film strip nutritional supplements and over-the-counter drugs. The Company's wholly owned subsidiary, InnoZen (http://www.innozen.com), is the preeminent formulator, developer and manufacturer of edible film strips that deliver drug actives through buccal (between the cheek and gum) absorption. InnoZen's proprietary edible film strip delivery technology is superior to any other competitive edible film strips currently on the market. InnoZen has five patents pending and has developed numerous trade secrets which it incorporates in the development and manufacturing process of edible film strips. The company's Enlyten™ SportStrips™ (http://enlytenstrips.com), an edible film electrolyte strip, has recently undergone and completed pre-market testing conducted in conjunction with physicians and scientists at Duke University Sports Medicine & The Michael J. Krzyzewski Human Performance Laboratory ("K Lab'') (http://klab.surgery.duke.edu). Preliminary findings of these tests suggest that the Enlyten electrolyte strip delivers meaningful amounts of electrolytes to the body in a safe, fast and effective manner.

Special Note Regarding Forward-Looking Statements: Statements in this news release about anticipated or expected future revenue or growth or expressions of future goals or objectives, including statements regarding whether current plans to grow and strengthen the Company's existing business, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements in this release are based upon information available to the Company on the date of this release. Any forward-looking statements involve risks and uncertainties, including the risk that the Company will be unable to grow or strengthen its business due to a lack of capital or an inability to identify acquisition candidates and that the Company may not realize anticipated cost savings or revenue growth opportunities associated with any acquisitions, planned or otherwise. Additionally, forward-looking statements concerning the performance of the Company's business are based on current market conditions and risks, which may change as the result of certain regulatory, competitive or economic events, as well as those risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, which could cause actual events or results to differ materially from the events or results described in the forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on these forward-looking statements.

Contact Information